about
Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adultsTreatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.Checkpoint inhibitors in Hodgkin's lymphoma.Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.Novel treatment concepts in Hodgkin lymphoma.Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin.Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients.
P2860
Q36450854-3273FC89-8B00-48D9-A16E-6295F1A965BFQ37683355-D7E46738-4865-4D4C-A23A-F3C14D2F05D6Q38631443-CAE17D11-30F3-4CE1-8401-0320125E85ADQ38664909-86BADC50-D096-48E1-A231-466C4D4196D5Q39043082-75F188A3-F386-4F74-9683-2FB19DD26B1BQ48190434-8CA7A560-7FD8-44D1-97BA-6400A5E67716Q52597560-596B6571-676A-4A23-BACC-F132399C2A70Q53183757-653F7523-BA80-4040-8CA4-A26FF47599D9
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The new therapeutical scenario of Hodgkin lymphoma.
@en
type
label
The new therapeutical scenario of Hodgkin lymphoma.
@en
prefLabel
The new therapeutical scenario of Hodgkin lymphoma.
@en
P2860
P356
P1433
P1476
The new therapeutical scenario of Hodgkin lymphoma.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDV256
P577
2015-06-02T00:00:00Z